SPIONs Conjugate Supported Anticancer Drug Doxorubicin’s Delivery: Current Status, Challenges, and Prospects

Considerable efforts have been directed towards development of nano-structured carriers to overcome the limitations of anticancer drug, doxorubicin’s, delivery to various cancer sites. The drug’s severe toxicity to cardio and hepatic systems, low therapeutic outcomes, inappropriate dose–demands, met...

Descripción completa

Detalles Bibliográficos
Autores principales: Akhtar, Naseem, Mohammed, Hamdoon A., Yusuf, Mohammed, Al-Subaiyel, Amal, Sulaiman, Ghassan M., Khan, Riaz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611558/
https://www.ncbi.nlm.nih.gov/pubmed/36296877
http://dx.doi.org/10.3390/nano12203686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611558/
https://www.ncbi.nlm.nih.gov/pubmed/36296877
http://dx.doi.org/10.3390/nano12203686

Ejemplares similares